that we are now analyzing, and preliminary results support our conclusions. One of the article's main findings-the correlation between worship attendance and religious coping and length of stay-could by definition only be studied in inpatients. It would be peculiar if, as Dr Watters asserts, religious involvement played a part in hospitalization and was also associated with reduced length of stay.
Dr Watters mistakenly attributes to us a finding that is actually a quote from a study by Neeleman and Lewis: "The intensity of religious beliefs was more pronounced among the more severely ill subjects" (1) . We note that in general our population had a high incidence of comorbidity and psychiatric hospitalizations, but in this study we did not compare the intensity of belief with the severity of illness.
The most interesting proposed "head-tohead" study is actually between 2 religious positions. Sellars, the author of the Humanist Manifesto I (1933), states elsewhere that humanism is really a nontheistic religion (2), perhaps making it an ideal choice for one of these positions. Such a study would not necessarily be definitive: it would just add to other studies like it. (3) is 20 years old. Since then, there has been a large increase in research on spirituality and mental health, with increasingly stringent methodology and controls for potential confounding variables. Batson and others (3, 4) , however, do note that religiousness has different components and that there are different ways to measure these aspects and mental health and types of mental illness. They actually conclude that findings depend on the way one measures religiousness and mental health and the confounders, such as social desirability. They did find that certain types of religiousness are associated with undesirable qualities. This is no surprise: like psychotherapy, medication, and hospitalization, religion can be distorted and misused. They also found that some types of religiousness are associated with positive qualities-but in convoluted thinking, any positive quality may be seen as a defence. Interestingly, they concluded that the more positive type of religiousness is associated with more frequent worship attendance.
The reference to Batson and others
We wish to clarify the obvious: the method did not set out to prove or demonstrate anything. The null hypothesis is that religion has no correlation with the dependent variables. We found this not to be the case. Dr Watters refers to this as "juggling statistical data." We find numbers and statistical analysis refreshing because they are logical and reproducible, unlike opinions. 
Oxcarbazepine Treatment of Posttraumatic Stress Disorder
Posttraumatic stress disorder (PTSD) can be a difficult illness, because current treatment options are only partly effective (1) . The disorder has been treated with anticonvulsants, based on the evidence that possible neuronal changes in the limbic system occur after exposure to trauma and cause a lowered arousal threshold that leads to reexperiencing symptoms (2) . The literature since the 1980s has reported that carbamezapine reduces PTSD reexperiencing symptoms (3) (4) (5) . I report a case in which a patient with PTSD was tried on numerous medications, including carbamezapine, and successfully treated with oxcarbazepine, which is chemically related to carbamezapine (6) .
Mr A, aged 46 years, had a history of chronic PTSD and was treated over the years with several medications, including carbamezapine, valproate, fluoxetine, sertraline, nefazodone, trazodone, paroxetine, clonazepam, and buspirone. He thought that carbamezapine had helped him, but he felt "drugged" and admitted to a lack of compliance caused by frequent blood draws to monitor his carbamezapine serum levels. On initial evaluation, Mr A was taking sertraline 150 mg daily and clonazepam 0.5 mg twice daily. Shortly after passing a significant anniversary date, he experienced frequent nightmares, intrusive thoughts, and flashbacks. His score on the Hamilton Anxiety Rating Scale (HARS) (7) was 23, and his score on the Clinical Global Impression Severity (CGI-S) (8) was 7. His condition left him dysphoric and fatigued, which contributed to occupational impairment. Mr A agreed to a trial of oxcarbazepine, begun at 150 mg twice daily. Initial laboratory tests included a complete blood count, hepatic enzymes, and serum electrolytes, all within normal limits. After 1 week, the oxcarbazepine was raised to 300 mg twice daily, and a serum sodium check was within normal limits. After 2 weeks at 300 mg twice daily, Mr A's dosage was increased to 450 mg twice daily. At this dosage, he began to experience less frequent and less severe nightmares. His HARS score decreased to 13, and his CGI Global Improvement score was 1. Mr A feels that he has significantly improved in all aspects of functioning since starting oxcarbazepine, especially at work. At 4 months, he maintains his high level of improvement, and his nightmares are infrequent.
Approved in the US in 1999, oxcarbazepine is an anticonvulsant used as an adjunct and as monotherapy to treat partial seizures in adults and as an adjunct to treat partial seizures in children from ages 4 to 16 years (9) . The primary mechanism of action appears to be blockage of voltage-dependent sodium channels (9) . The drug is structurally related to carbamezapine but is not metabolized to the 10,11-epoxide, which lessens the incidence of side effects associated with carbamezapine (10) . Studies have shown oxcarbazepine to be as effective and better tolerated by patients having difficulties with carbamezapine, although this observation pertains to patients with epilepsy (10). Although hematologic and hepatic toxicity have not been reported, hyponatremia has been associated with oxcarbazepine (9) . Common side effects related to oxcarbazepine use appear to be dosage-related and include somnolence, dizziness, vomiting, and nausea (11) . Oxcarbazepine does not require serum monitoring (12); thus, frequent blood testing is not needed. Because this had been a factor in this patient's previous noncompliance, and because he had experienced a decrease in his PTSD symptoms while on carbamezapine, he was expected to do well on oxcarbazepine. As with all single-case reports, caution is advised in interpreting results; however, based on this case, further studies done in a controlled fashion may be warranted.
Timothy Berigan, DDS, MD Tucson, Arizona

Voice Mail as a Transitional Object in the Treatment of Borderline Personality Disorder
Dear Editor:
One of the psychodynamic theories related to borderline personality disorder (BPD) is that the patient was unable as a child to traverse the rapprochement subphase of the separation-individuation process described by Mahler. As a result, the patient was unable to develop a sense of emotional object constancy (1, 2) . Adler formulated such patient difficulties as an inability to maintain holding and soothing introjects when faced with separations (1). Winnicott described how children use transitional objects to help tolerate negative affects and aloneness until evocative memory is established (1). Psychiatric staff commonly observe an association between a diagnosis of BPD and the presence of transitional objects on the inpatient ward (3, 4) .
In therapy with patients having BPD, it is important to create a containing environment (1) . This can help the patient manage anger and other painful feelings that are triggered by separations from the therapist and can lead to increasing suicidality (1) . Adler describes the use of transitional objects to create a holding therapy environment (1) . However, some therapists express concern that the use of transitional objects can be gratifying and promote regression and dependency.
As a junior resident working in therapy with a patient suffering from BPD, I was always unsettled by panicky phone calls. My patient, a First Nations woman who had experienced severe childhood abuse and neglect, sometimes called from a closet where she held a knife to her chest. I was surprised to find how little intervention it took to settle the situation: it seemed that just hearing my voice was enough. Later in therapy, I acquired voice mail. She confessed to me that she frequently called my voice mail between sessions to hear my voice and that this helped her. Since that experience, I have had several other patients with BPD who have used voice mail in this way. Some find the experience "grounding," while others find that it reinforces my role as the caring therapist.
Voice mail is a standard way of receiving messages that can provide a personal message 24 hours daily, 7 days a week. It is not a gift for the patient, nor is it created especially for the patient. There is no limit to the length of the message left. Conversely, the caller can choose not to leave a message, and the receiver will be unaware of the call. Patients can be warned that there may be a variable delay before a call is returned, and other plans for access to immediate resources can be discussed, as appropriate. The use of voice mail by a patient with BPD in some ways mimics the rapprochement phase, because the patient can use the therapist's voice as a way of checking back and "refuelling" between sessions. However, voice mail does not gratify the patient with the therapist's presence. Moreover, use of voice mail can be explored within therapy sessions.
In therapy with patients having BPD, voice mail is a tool that can assist in
